We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Epimax Ointment and Epimax Paraffin-Free Ointment can harm the eyes if used on the face. Do not prescribe these ointments for use on the face. Tell patients to wash their hands and avoid touching their eyes after using these products.
These publications explain diabetic retinopathy and support the NHS diabetic eye screening (DES) programme.
Population screening programmes: NHS diabetic eye screening (DES) programme
Guidance for the NHS diabetic eye screening (DES) programme.
This document sets out the programme specific operating model for quality assurance of the NHS diabetic eye screening (DES) programme.
Advice on making reasonable adjustments to eye care services so they are accessible to people with learning disabilities.
Executive summaries from local screening quality assurance (QA) visit reports of diabetic eye screening services, including recommendations.
This table sets out the 2021 to 2022 data for the local diabetic eye screening (DES) services in England.
Specific batches of carbomer gel are being recalled as a precaution due to possible microbiological contamination.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).